143 related articles for article (PubMed ID: 18483276)
21. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
22. Paracrine and transpresentation functions of IL-15 are mediated by diverse splice versions of IL-15Rα in human monocytes and dendritic cells.
Müller JR; Waldmann TA; Kruhlak MJ; Dubois S
J Biol Chem; 2012 Nov; 287(48):40328-38. PubMed ID: 23074221
[TBL] [Abstract][Full Text] [Related]
23. Elucidation of the interleukin-15 binding site on its alpha receptor by NMR.
Hanick NA; Rickert M; Varani L; Bankovich AJ; Cochran JR; Kim DM; Surh CD; Garcia KC
Biochemistry; 2007 Aug; 46(33):9453-61. PubMed ID: 17655329
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.
Larrea E; Riezu-Boj JI; Aldabe R; Guembe L; Echeverria I; Balasiddaiah A; Gastaminza P; Civeira MP; Sarobe P; Prieto J
Gut; 2014 Apr; 63(4):665-73. PubMed ID: 23787026
[TBL] [Abstract][Full Text] [Related]
25. Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia.
Chen J; Petrus M; Bamford R; Shih JH; Morris JC; Janik JE; Waldmann TA
Blood; 2012 Jan; 119(1):137-43. PubMed ID: 22049515
[TBL] [Abstract][Full Text] [Related]
26. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
Tartour E; Deneux L; Mosseri V; Jaulerry C; Brunin F; Point D; Validire P; Dubray B; Fridman WH; Rodriguez J
Cancer; 1997 Apr; 79(7):1401-8. PubMed ID: 9083163
[TBL] [Abstract][Full Text] [Related]
27. IL-15/sIL-15Rα gene transfer suppresses Lewis lung cancer growth in the lungs, liver and kidneys.
Sun H; Liu D
Cancer Gene Ther; 2016; 23(2-3):54-60. PubMed ID: 26742578
[TBL] [Abstract][Full Text] [Related]
28. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
29. Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity.
Bergamaschi C; Rosati M; Jalah R; Valentin A; Kulkarni V; Alicea C; Zhang GM; Patel V; Felber BK; Pavlakis GN
J Biol Chem; 2008 Feb; 283(7):4189-99. PubMed ID: 18055460
[TBL] [Abstract][Full Text] [Related]
30. Adipocytes: A Novel Target for IL-15/IL-15Rα Cancer Gene Therapy.
Xiao R; Mansour AG; Huang W; Chrislip LA; Wilkins RK; Queen NJ; Youssef Y; Mao HC; Caligiuri MA; Cao L
Mol Ther; 2019 May; 27(5):922-932. PubMed ID: 30833178
[TBL] [Abstract][Full Text] [Related]
31. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.
Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334
[TBL] [Abstract][Full Text] [Related]
32. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
Wittnebel S; Da Rocha S; Giron-Michel J; Jalil A; Opolon P; Escudier B; Validire P; Khawam K; Chouaib S; Azzarone B; Caignard A
Cancer Res; 2007 Jun; 67(12):5594-9. PubMed ID: 17575122
[TBL] [Abstract][Full Text] [Related]
33. Different NK cell developmental events require different levels of IL-15 trans-presentation.
Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human heterodimeric IL-15 complex displays extensive and reproducible N- and O-linked glycosylation.
Thaysen-Andersen M; Chertova E; Bergamaschi C; Moh ES; Chertov O; Roser J; Sowder R; Bear J; Lifson J; Packer NH; Felber BK; Pavlakis GN
Glycoconj J; 2016 Jun; 33(3):417-33. PubMed ID: 26563299
[TBL] [Abstract][Full Text] [Related]
35. Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum.
Bergamaschi C; Bear J; Rosati M; Beach RK; Alicea C; Sowder R; Chertova E; Rosenberg SA; Felber BK; Pavlakis GN
Blood; 2012 Jul; 120(1):e1-8. PubMed ID: 22496150
[TBL] [Abstract][Full Text] [Related]
36. Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer.
Morris JC; Ramlogan-Steel CA; Yu P; Black BA; Mannan P; Allison JP; Waldmann TA; Steel JC
Gene Ther; 2014 Apr; 21(4):393-401. PubMed ID: 24572789
[TBL] [Abstract][Full Text] [Related]
37. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
38. Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions.
Azzi S; Gallerne C; Romei C; Le Coz V; Gangemi R; Khawam K; Devocelle A; Gu Y; Bruno S; Ferrini S; Chouaib S; Eid P; Azzarone B; Giron-Michel J
Neoplasia; 2015 Jun; 17(6):509-17. PubMed ID: 26152359
[TBL] [Abstract][Full Text] [Related]
39. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
40.
Anton OM; Peterson ME; Hollander MJ; Dorward DW; Arora G; Traba J; Rajagopalan S; Snapp EL; Garcia KC; Waldmann TA; Long EO
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):522-531. PubMed ID: 31871169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
